Tretinoin

What it is

Tretinoin is all-trans retinoic acid, the acid form of vitamin A, applied to skin as a cream, gel or lotion. The US label indication is acne, and it says safety and efficacy for other disorders have not been established (label). It is not approved for hair loss anywhere and is prescription-only in the US. Over-the-counter retinol products are weaker, different molecules with no hair-loss data here.

In hair care it is either mixed into compounded minoxidil solutions (0.01% in the study below) or applied to the scalp before minoxidil.

How it works

• Absorption. In 19 healthy men, 0.05% tretinoin cream once daily raised absorption of 2% minoxidil almost threefold (versus 1.3-fold with a vehicle cream), consistent with a more permeable skin barrier (Ferry 1990).
• Enzyme activation. Minoxidil must be sulfated in the follicle to work. A 2019 study reported that tretinoin raised follicular sulfotransferase and that 43% of people predicted to be non-responders were "converted" after 5 days. It is a small mechanism study from a group tied to a commercial response test, not an outcome trial (Sharma 2019).
• A 2026 review credits both mechanisms but says clinical data on the combination are minimal (Maas 2026). See minoxidil for the background.

What the studies show

• A 1986 controlled trial of 56 people reported terminal regrowth in 66% on tretinoin with 0.5% minoxidil and about 58% on tretinoin alone after a year; it is preliminary and predates modern hair-count methods (Bazzano 1986).
• The only modern randomised trial gave 31 men 5% minoxidil plus 0.01% tretinoin once daily or 5% minoxidil twice daily. Both increased hair counts with no significant difference, and irritation was similar. That shows "equivalent with fewer applications", not "better" (Shin 2007).
• The 2026 review found one RCT with similar outcomes, some small studies suggesting non-responders can convert, and does not support first-line dual therapy (Maas 2026).

How it's used in studies

• 0.01% tretinoin combined with 5% minoxidil, applied once daily at night (Shin 2007); 0.05% tretinoin cream once daily before minoxidil in the absorption study (Ferry 1990). Real-world compounding concentrations vary widely.

Side effects and safety

• Irritation, redness, peeling, stinging, dryness and sun sensitivity are the main effects, reversible after stopping (label).
• Pregnancy: the label says to use it in pregnancy only if the benefit justifies the risk; animal studies showed fetal harm at high, mainly oral, doses. Topical-retinoid birth-defect risk is debated and data are limited. Avoid when pregnant or trying to conceive unless a clinician advises otherwise.
• Because tretinoin roughly triples minoxidil absorption, systemic minoxidil effects could in theory rise; this has not been measured in people with hair loss.
• Oral vitamin A derivatives are a known cause of hair shedding, a different route and dose from scalp tretinoin (Tosi 1994).

Bottom line

Tretinoin is a plausible, cheap add-on for someone who has used minoxidil for six months or more with little response, but there is no good evidence it beats minoxidil alone and it adds irritation. A 2026 review reaches the same position: not first-line, perhaps an adjunct for non-responders. It needs a prescriber or compounding pharmacy. Discuss with a doctor.